Federal Legislation and Regulation Resources
PRESS RELEASE: Doctors for America Condemns Lawsuits by Merck and U.S. Chamber of Commerce That Put Profits Over Patients
A Call for Health For All
Improving Health and Health Care: Values and Principles for Values and Principles for Transformation
Statement on the Anniversary of the Enactment of the Affordable Care Act
Statement on the Ending of Medicaid Continuous Enrollment Provision
Stay Up-to-Date
Happening Now
STATEMENT RELEASE: Makena Statement
Prescription Drugs, FDA
PRESS RELEASE: Doctors for America’s FDA Task Force Applauds Senate End of Year Package
Health for All, Prescription Drugs, FDA
PRESS RELEASE: Doctors for America’s FDA Task Force Meets Legislators for a Third Time Ahead of End of Year Package
Health for All, Prescription Drugs, FDA
Members in Action
Upcoming Events
Loading view.
All times are in Eastern Time unless otherwise noted.
Federal preemption and its impact on state restrictions limiting access to mifepristone and abortion care
Virtual Event
Session Overview The FDA’s Risk Evaluation and Mitigation Strategy (REMS) for mifepristone allows patients to obtain the drug without an in-person visit to a clinician. Ongoing federal litigation has challenged...
All DFA Advocate Call
The road ahead is filled with uncertainty, fear and many challenges, especially for those most marginalized and most vulnerable among us. However, Doctors for America advocates have fought these battles...